Power with energy saving

For its new research center in Parma, Chiesi has adopted more than 100 drives (at a power between 0.75 and 55 kW) produced by Control Techniques, whose technical skills and consulting services have been again appreciated.

For over 10 years Control Techniques (Emerson Industrial Automation Division) has been supplying its inverters to Chiesi Farmaceutici that, in order to study more innovative products and evermore targeted solutions for the treatment of chronic respiratory illnesses and rare pathologies, has created a new research center in Parma, destined to become the company’s corporate R&D headquarters.
Built with special attention to energy saving and environmental impact, the new center, with a high level of automation, has been designed to optimally integrate all the processes related to the various phases of research.
Control Techniques in this regard, working with Chiesi’s technical engineering department, has contributed to the development of solutions that reduce operating costs of the various different systems. And, as a result of energy analysis carried out covering all asynchronous motors of the new research center, Chiesi has decided to install the Control Techniques drives to handle its central heating, refrigeration and air purification facilities.
The choice fell on Affinity, which proved to be the ideal product: a specific drive for HVAC/R applications with dedicated features such as IP54 protection, integrated EMC filter, multilingual LCD alphanumeric keypad and Smartcard for the setup and transfer of parameters. Affinity, a Control Techniques product, enables the variation of the frequency and the power voltage of the asynchronous motors, adapting the speed and torque to the actual needs of the charge, providing all the information on the converter and the motor on the alphanumeric operator panel or via fieldbus, on the data collection consol.
But this is not all. Affinity’s high grade of protection means that frequency converters can be installed in the immediate vicinity of the specific facilities, thus helping to reduce installation costs.       

Chiesi Farmaceutici, set up in Parma as a provincial laboratory, in seventy-five years has become an international company with a workforce of over 3,800 people. The company, which operates on all five continents with 24 direct subsidiaries, 3 manufacturing plants and 4 research centers, focuses on respiratory pathologies, specialist medicine and cardiovascular diseases. Constantly engaged in R&D the company has filed 1,273 patents active worldwide.